Add to watchlist
€3.52
Last updated:06/14/2021
04K: F
Knight Therapeutics Inc

Knight Therapeutics Inc., a specialty pharmaceutical company, develops, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices in Canada and internationally. It offers Bijuva for the treatment of moderate to seve… Show more

P/E ratio
14.25x
vs. 263.16x forward

Price is 14.25x times more than EPS €0.247 which eaquals €3.52

Stock volatility (Beta)
past 12 months

Become our supporter to unlock all data!
Company results
Quarterly
Annual
Fundamentals
2017
2018
2019
2020
Net Income
Income minus expenses, depreciation, interest, taxes, and other expenses
17.244M
24.079M
+39.64%
14.517M
-39.71%
42.067M
+189.78%
Cashflow
Sum up money going in and out company
23.457M
-5.739M
-124.47%
4.596M
+180.08%
-12.205M
-365.56%
Total liabilities
All combined debts and obligations
14.775M
21.8M
+47.55%
390.197M
+1689.89%
153.435M
-60.68%
Company profile
CEO
Mr. Jonathan Ross Goodman B.A., L.L.B., M.B.A., BA, LLB, MBA
Market capitalization
Small (0.45B)